Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.779
+0.064 (2.37%)
May 14, 2026, 10:30 AM EDT - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $944.94 million as of May 14, 2026. Its market cap has decreased by -36.02% in one year.
Market Cap
944.94M
Enterprise Value
877.85M
1-Year Change
-36.02%
Ranking
Category
Stock Price
$2.78
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $944.94M, an increase of 157.97%. That is a compound annual growth rate of 6.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 944.94M | -16.88% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phibro Animal Health | 1.47B |
| Harrow | 1.42B |
| Collegium Pharmaceutical | 1.16B |
| Alvotech | 1.12B |
| Xeris Biopharma Holdings | 1.06B |
| Cronos Group | 953.79M |
| Pacira BioSciences | 894.77M |
| Eton Pharmaceuticals | 816.42M |